We evaluated immunohistochemical staining for GDF15 in pretreatment biopsy specimens of 230 of 256 OSCC patients who were treated in a prospective , randomized , phase III trial on induction chemotherapy including docetaxel , cisplatin and 5-fluorouracil ( TPF ) .